Phase
Condition
Fast Heart Rate (Tachycardia)
Heart Defect
Cardiac Disease
Treatment
AtriCure Commercially Available Devices
Clinical Study ID
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subject is scheduled to undergo or has undergone a procedure to treat IST or POTSusing one or more AtriCure devices.
Subject is willing to provide written informed consent (defined as legallyeffective, documented confirmation of a subject's voluntary agreement to participatein this Registry) or authorization per institution and geographical requirements
Exclusion
Exclusion Criteria:
Subject is enrolled in a concurrent study that may impact treatment outcome of ISTor POTS.
Subject with exclusion criteria required by FDA or local governance
Study Design
Connect with a study center
Universitair Ziekenhuis Brussels
Brussels,
BelgiumActive - Recruiting
Stanford University
Palo Alto, California 94305
United StatesActive - Recruiting
Sequoia Hospital
Redwood City, California 94062
United StatesActive - Recruiting
University of Florida
Gainesville, Florida 32608
United StatesActive - Recruiting
Sarasota Memorial Hospital
Sarasota, Florida 34239
United StatesActive - Recruiting
Saint Alphonsus Regional Medical Center
Boise, Idaho 83704
United StatesSite Not Available
Kansas City Cardiac Arrhythmia Research
Kansas City, Kansas 64132
United StatesActive - Recruiting
MedStar Health Research Institute
Hyattsville, Maryland 20782
United StatesActive - Recruiting
The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital
Cincinnati, Ohio 45219
United StatesActive - Recruiting
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas 78705
United StatesActive - Recruiting
Intermountain Medical Center
Murray, Utah 84107
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.